| risperidone / Generic mfg. |
2008-001015-38: A randomized, placebo-controlled study of the central cannabinoid (CB1) receptor antagonist rimonabant as adjunctive therapy to improve cognition in schizophrenia |
|
|
| Ongoing | 3 | 70 | Europe | Risperidone, Rimonabant, Film-coated tablet, Risperidone, Rimonabant | LWL University Hospital Bochum, Ruhr-University Bochum | Schizophrenia | | | | |
2005-002979-33: Estudio de la eficacia y seguridad de risperidona en el tratamiento de adolescentes con esquizofrenia: Estudio abierto de seis meses. |
|
|
| Ongoing | 3 | 8 | Europe | Risperdal 1mg, F5, Risperdal1 mg, Risperdal1 mg | Janssen-Cilag International N.V. | SCHIZOPHRENIA/ Adolescents | | | | |
2008-003623-23: Effect of different antipsychotic medication on craving related brain activity in patients with schizophrenia and cannabis abuse or dependence:a randomized controlled study comparing clozapine and risperidone. |
|
|
| Ongoing | 3 | 70 | Europe | Clozapine, Risperidone, | Academisch medisch centrum, department of psychiatry | A randomized controlled trial comparing the effect of clozapine and risperidone on cannabis craving in cannabis abusing or dependent patients with schizophrenia. Specific cognitive tasks will be used to test craving pathways and associated brain activities are assessed with functional MRI. | | | | |
2009-011594-33: A randomized, double-blind, placebo-controlled study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia |
|
|
| Ongoing | 3 | 60 | Europe | Risperidone, Tetrabenazine, Risperdal, Risperdal | LWL University Hospital Bochum, Ruhr-University Bochum | Schizophrenia | | | | |
2013-004881-33: Multicentre trial in to investigate the usage of antidepressant and antipsychotics (with / without approval) in patients at the age of children and adolescents Groß an gelegte, einfache offene klinische Studie mit mehreren teilnehmenden Prüfzentren zur Anwendung von Antidepressiva und Neuroleptika (mit /ohne Zulassung) |
|
|
| Ongoing | 3 | 1000 | Europe | Tablet, Abilify, Zyprexa, Leponex, Seroquel, Risperdal, Zeldox, Melneurin, Dipiperon, Saroten, Cipramil, Anafranil, Aponal, Cymbalta, Cipralex, Fluctin, Fevarin, Tofranil, Ludiomil, Remergil, Nortrilen, Paroxat, Zoloft, Stangyl, Trevilor | Universitätsklinikum Würzburg, Kompetenznetz TDM-KJP e.V., BfArM | therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, therapeutic use in clinical practise Therapeutische Anwendung im klinischen Alltag, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2016-002859-19: Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail? Antipsychotica afbouwen bij mensen met een verstandelijke beperking: waarom lukt het niet? |
|
|
| Ongoing | 3 | 126 | Europe | Risperidone, Pipamperone, Oral liquid, Risperidone, Pipamperone | Erasmus MC, Abrona, Ipse de Bruggen, Amarant | People with challenging behavior and off-label antipsychotic use Mensen met een verstandelijke beperking en gedragsproblemen waarvoor offlabel antipsychotica gebruik, People with challenging behavior and off-label antipsychotic use Mensen met een verstandelijke beperking en gedragsproblemen waarvoor offlabel antipsychotica gebruik, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
NCT05779241: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 |
|
|
| Completed | 3 | 83 | US | LYN-005, Risperidone, Risperdal | Lyndra Inc. | Schizophrenia, Schizoaffective Disorder | 11/23 | 12/23 | | |
2020-006062-36: A Phase II/III, randomized, 4-week, placebo-controlled study, designed to determine the safety, tolerability, and efficacy of evenamide (NW-3509) in patients with chronic schizophrenia. |
|
|
| Ongoing | 2/3 | 196 | Europe, RoW | Evenamide, NW3509, Capsule, hard | Newron Pharmaceuticals S.p.A., NEWRON PHARMACEUTICALS SPA, Newron Pharmaceuticals S.p.A, Newron Pharmaceuticals S.p.A., Newron Pharmaceuticals S.p.A | Chronic schizophrenia, Chronic schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
